Tag: Patrick Loofbourrow
Six firms assist on AstraZeneca’s USD1.2bn Gracell purchase
Six firms act for parties involved with Anglo-Swedish pharmaceutical giant AstraZeneca’s acquisition of Chinese peer Gracell Biotechnologies for USD1.2 billion
Structure Therapeutics raises USD180m in ADS offering
Biopharmaceutical company Structure Therapeutics raised USD134 million in a Nasdaq listing, offering 8.95 million American depositary shares (ADS) priced at USD15 each
LATEST ON LAW.ASIA
No flaws allowed
While stock exchanges lower barriers to atrract emerging sector issuers, regulators focus on accountability of listco and intermediaries at the top corporate level
